- Price
- $407.50
- Day
- -1.76%
- Mkt Cap
- $88.37B
- 52W Range
- $274.84 – $436.24
- Volume
- 1.04M
- Beta
- 0.69
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a rare legal protection most will never realize they have.
Read full article
Allen Mooney and Barnes Investment Advisors LLC cut its stake in Elevance Health, Inc. (NYSE: ELV) by 6.5% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 46,398 shares of the company's stock after selling 3,218 shares during the quarter.
Read full article
Beaconlight Capital LLC bought a new position in shares of Elevance Health, Inc. (NYSE: ELV) in the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund bought 5,946 shares of the company's stock, valued at approximately $2,299,000. Elevance Health makes up about 0.8% of Beaconlight Capital LLC's
Read full article
On August 25, 2026, we delve into the DCF analysis for Elevance Health Inc (ELV), a company that has shown impressive price performance recently, with a year-to
Read full article
UNH outpaces ELV with stronger earnings prospects, improving Medicare profitability, greater upside and a more favorable risk-reward profile.
Read full article
Barrow Hanley Mewhinney and Strauss LLC purchased a new stake in shares of Elevance Health, Inc. (NYSE: ELV) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 452,636 shares of the company's stock, valued at approximately $175,048,000. Barrow Hanley Mewhinney and
Read full article
B. Metzler seel. Sohn and Co. AG purchased a new position in Elevance Health, Inc. (NYSE: ELV) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 31,408 shares of the company's stock, valued at approximately $12,146,000. Other institutional investors have also
Read full article
Asahi Life Asset Management CO. LTD. purchased a new stake in Elevance Health, Inc. (NYSE: ELV) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 1,279 shares of the company's stock, valued at approximately $495,000. Several other large investors have also
Read full article
Avise Financial Cooperative Inc. acquired a new stake in Elevance Health, Inc. (NYSE: ELV) in the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 1,633 shares of the company's stock, valued at approximately $632,000. A number of other hedge funds and other institutional investors
Read full article
Barden Capital Management Inc. acquired a new position in Elevance Health, Inc. (NYSE: ELV) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 1,609 shares of the company's stock, valued at approximately $622,000. A number of other institutional investors
Read full article